6-N-acyltriciribine analogues: Structure - activity relationship between acyl carbon chain length and activity against HIV-1

Journal of Medicinal Chemistry

Volumn 43, Issue 12, 2000, Pages 2457-2463

  Porcari, Anthony R ^a,c   Ptak, Roger G ^b,c   Borysko, Katherine Z ^c   Breitenbach, Julie M ^c   Drach, John C ^c   Townsend, Leroy B ^c  

^a PFIZER INC   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRICIRIBINE; TRICIRIBINE 5' MONOPHOSPHATE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CELL DIVISION; CELL LINE; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 1, HUMAN; HIV-1; HUMANS; INHIBITORY CONCENTRATION 50; PLAQUE ASSAY; RIBONUCLEOSIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033934161     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990236h     Document Type: Article

References (29)

1. Schram, K. H.; Townsend, L. B. The synthesis of 6-amino-4-methyl-8-(Deta-D-ribofuranosyl)(4-H,8-H)pyrrolo[4,3,2-de]pyrimido-[4, 5-c]pyridazine, A new tricyclic nucleoside. Tetrahedron Lett. 1971, 49, 4757-4760.
2. Roti Roti, L. W.; Roti Roti, J. L.; Townsend, L. B. Studies on the mechanism of cytotoxicity of tricyclic nucleoside NSC#154020 in L1210 cells. Proc. Am. Assoc. Cancer Res. 1978, 19, 40.
3. Schweinsberg, P. D.; Smith, R. G.; Loo, T. L. Identification of the metabolites of an antitumor tricyclic nucleoside (NSC-154020). Biochem. Pharmacol. 1981, 30, 2521-2526.
4. Wotring, L. L.; Townsend, L. B.; Crabtree, G. W.; Parks, R. E., Jr. A possible role for ecto-5′-nucleotidase in cytotoxicity and intracellular nucleotide formation from the tricyclic nucleoside-5′-phosphate (TCN-P). Proc. Am. Assoc. Cancer Res. 1981, 22, 257.
5. Wotring, L. L.; Passiatore, J. E.; Roti Roti, J. L.; Hudson, J. L.; Townsend, L. B. Effects of the tricyclic nucleoside 6-amino-4-methyl-8-(beta-D-ribofuranosyl)pyrrolo[4,3,2-de]pyrimido[4,5-c] pyridazine on the viability and cell cycle distribution of L1210 cells in vitro. Cancer Res. 1985, 45, 6355-6361.
6. Wotring, L. L.; Townsend, L. B.; Jones, L. M.; Borysko, K. Z.; Gildersleeve, D. L.; Parker, W. B. Dual mechanisms of inhibition of DNA synthesis by triciribine. Cancer Res. 1990, 50, 4891-4899.
7. Moore, E. C.; Hurlbert, R. B.; Boss, G. R.; Massia, S. P. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P). Biochem. Pharmacol. 1989, 38, 4045-4051.
8. Townsend, L. B.; Lewis, A. F.; Roti Roti, L. W. Synthesis of 6-amino-4-methyl-8-(beta-D-ribofuranosyl)pyrrolo[4,3,2-de]pyrimido[4,5-c] pyridazine-5′-phosphate as a novel compound and its utility against L-1210 mouse leukemia. United States. Patent Number: 4,123,524. October 31, 1978.
9. Wotring, L. L.; Crabtree, G. W.; Edwards, N. L.; Parks, R. E., Jr.; Townsend, L. B. Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCN. Cancer Treat. Rep. 1986, 70, 491-497.
10. Kucera, L. S.; Iyer, N. P.; Puckett, S. H.; Buckheit, R. W., Jr.; Westbrook, L.; Toyer, B. R.; White, E. L.; Germany-Decker, J. M.; Shannon, W. M.; Chen, R. C.; Nassiri, M. R.; Shipman, C.; Townsend, L. B.; Drach, J. C. Activity of triciribine and triciribine-5′-monophosphate against human immunodeficiency virus types 1 and 2. AIDS Res. Hum. Retroviruses. 1993, 9, 307-314.
11. Ptak, R. G.; Jacobson, J. G.; Borysko, K. Z.; Townsend, L. B.; Drach, J. C. Triciribine inhibits HIV nuclear import and requires phosphorylation by cellular enzymes for activity. 5th Conf. Retroviruses & Opportunistic Infections. Chicago, IL. 1998. abst. 354.
12. Ptak, R. G.; Borysko, K. Z.; Porcari, A. R.; Buthod, J. L.; Holland, L. E.; Shipman, C.; Townsend, L. B.; Drach, J. C. Phosphorylation of triciribine is necessary for activity against HIV-1. AIDS Res. Human Retroviruses. 1998, 14, 1315-1322.
13. Ptak, R. G.; Drach, J. C.; Jacobson, J. G.; Townsend, L. B.; Stup, T. L.; Russell, J.; Buckheit, R. W. HIV-1 Regulatory Proteins: Targets of Triciribine? 6th Conf. Retroviruses & Opportunistic Infections. Chicago, IL. February, 1999. abst. 622.
14. Drach, J. C.; Shipman, C.; Ptak, R. G.; Borysko, K. Z.; Jacobson, J. G.; Nassiri, M. R.; Wotring, L. L.; Porcari, A. R.; Townsend, L. B. Activity of triciribine (TCN) against HIV-1 requires cellular phosphorylation and inhibition of a viral gene product. 36th Interscience Conf. Antimicrob. Agents Chemother. New Orleans, LA. 1996. abst. 2099.
15. Ickes, D. E.; Shipman, C.; Drach, J. C. Antiviral activity of triciribine and triciribine monophosphate against human herpesvirus type 6. Seventh International Conference on Antiviral Research. Charleston, SC. 1994.
16. Musherure, P. R.; Breitenbach, J. M.; Aseltine, K. R.; Shipman, C.; Drach, J. C. Antiviral activity of triciribine (TCN) in combination with phosphonoformate (PFA) on human herpesvirus type 6 (HHV-6). AADR Meeting. San Antonio, TX. 1995. abst. 391.
17. Nassiri, M. R.; Achim, C. L.; Martinez, A. J.; Wiley, C. A.; Drach, J. C.; Townsend, L. B. Antiretroviral activity of TCN-P in HIV-infected Human Macrophages. Eleventh International Conference on Antiviral Research. San Diego, CA. 1998.
18. Porcari, A. R.; Drach, J. C.; Wotring, L. L.; Townsend, L. B. The design, synthesis and evaluation of a series of acyclic triciribine analogues for their antiviral and antineoplastic activity. 213th National Meeting of the American Chemical Society. San Francisco, CA. 1997. abst. MEDI 269.
19. Porcari, A. R.; Drach, J. C.; Wotring, L. L.; Townsend, L. B. Synthesis and structure-activity relationship of a series of deoxy triciribine analogues against HIV and murine L1210 cells. 214th National Meeting of the American Chemical Society. Las Vegas, NV. 1997. abst. MEDI 181.
20. Turk, S. R.; Shipman, C., Jr.; Nassiri, M. R.; Genzlinger, G.; Krawczyk, S. H.; Townsend, L. B.; Drach, J. C. Pyrrolo[2,3-d]-pyrimidine nucleosides as inhibitors of human cytomegalovirus. Antimicrob. Agents Chemother. 1987, 31, 544-550.
21. Nara, P. L.; Hatch, W. C.; Dunlop, N. M.; Robey, W. G.; Fischinger, P. J. Simple, rapid quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retroviruses. 1987, 3, 283-302.
22. Nara, P. L.; Fischinger, P. J. Quantitative infectivity assay for HIV-1 and -2. Nature 1988, 332, 469-470.
23. Chaffee, S.; Leeds, J. M.; Matthews, T. J.; Weinhold, K. J.; Skinner, M.; Bolognesi, D. P.; Hershfield, M. S. Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J. Exp. Med. 1988, 168, 605-621.
24. Kucera, L. S.; Iyer, N.; Leake, E.; Raben, A.; Modest, E. J.; Daniel, L. W.; Piantadosi, C. Novel membrane-interactive ether lipid analogues that inhibit infectious HIV-1 production and induce defective virus formation. AIDS Res. Hum. Retroviruses. 1690, 6, 491-501.
25. White, E. L.; Buckheit, R. W.; Ross, L. J.; Germany, J. M.; Andries, K.; Pauwels, R.; Janssen, P. A. J.; Shannon, W. M.; Chirigos, M. A. ATIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. Antiviral Res. 1991, 16, 257-266.
26. Prichard, M. N.; Shipman, C. A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 1990, 14, 181-206.
27. Prichard, M. N.; Prichard, L. E.; Baguley, W. A.; Nassiri, M. R.; Shipman, C. Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine. Antimicrob. Agents Chemother. 1991, 35, 1060-1065.
28. Pogolotti, A. L.; Santi, D. V. High-pressure liquid chromatography-Ultraviolet analysis of intracellular nucleotides. Anal. Biochem. 1982, 126, 335-345.
29. Walseth, T. F.; Graff, G.; Moos, M. C.; Goldberg, N. D. Separation of 5′-ribonucleoside monophosphates by ion-pair reverse-phase high-performance liquid chromatography. Anal. Biochem. 1980, 107, 240-245.